Hologic, Inc. (HOLX) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HOLX Revenue Growth
Revenue Breakdown (FY 2025)
HOLX's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
By Geography
HOLX Revenue Analysis (2014–2025)
As of May 8, 2026, Hologic, Inc. (HOLX) generated trailing twelve-month (TTM) revenue of $4.13 billion, reflecting modest growth of +2.5% year-over-year. The most recent quarter (Q1 2026) recorded $1.05 billion in revenue, down 0.2% sequentially.
Looking at the longer-term picture, HOLX's 5-year compound annual growth rate (CAGR) stands at +1.7%, indicating moderate growth over time. The company achieved its highest annual revenue of $5.63 billion in 2021.
Revenue diversification analysis shows HOLX's business is primarily driven by Diagnostics (45%), Breast Health (36%), and Gyn Surgical (17%).
When compared to Healthcare sector peers including BDX (+2.4% YoY), BAX (+5.1% YoY), and IDXX (+13.1% YoY), HOLX has underperformed the peer group in terms of revenue growth. Compare HOLX vs BDX →
HOLX Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HOLXCurrent | $4.1B | +2.5% | +1.7% | 17.4% | |
 BDX | $21.8B | +2.4% | +6.3% | 11.8% | |
 BAX | $11.2B | +5.1% | -0.7% | -2.7% | |
 IDXX | $4.3B | +13.1% | +9.7% | 31.6% | |
 DXCM | $4.7B | +16.2% | +19.3% | 19.6% | |
 ISRG | $10.1B | +21.4% | +18.2% | 29.3% |
HOLX Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.10B | +1.7% | $2.50B | 61.0% | $714.3M | 17.4% |
| 2024 | $4.03B | -0.0% | $2.23B | 55.3% | $882.6M | 21.9% |
| 2023 | $4.03B | -17.1% | $2.07B | 51.4% | $668.4M | 16.6% |
| 2022 | $4.86B | -13.7% | $3.00B | 61.6% | $1.64B | 33.7% |
| 2021 | $5.63B | +49.1% | $3.80B | 67.4% | $2.48B | 44.0% |
| 2020 | $3.78B | +12.1% | $2.23B | 59.0% | $1.10B | 29.3% |
| 2019 | $3.37B | +4.6% | $1.31B | 38.8% | $134.4M | 4.0% |
| 2018 | $3.22B | +5.2% | $1.70B | 52.7% | $-237,900,000 | -7.4% |
| 2017 | $3.06B | +8.0% | $1.62B | 53.0% | $1.37B | 44.8% |
| 2016 | $2.83B | +4.7% | $1.56B | 55.2% | $548.6M | 19.4% |
Full HOLX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See HOLX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HOLX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HOLX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHOLX — Frequently Asked Questions
Quick answers to the most common questions about buying HOLX stock.
Is HOLX's revenue growth accelerating or slowing?
HOLX revenue growth slowed to +2.5%, below the 5-year CAGR of +1.7%. TTM revenue is $4.1B. The deceleration marks a shift from historical growth rates.
What is HOLX's long-term revenue growth rate?
Hologic, Inc.'s 5-year revenue CAGR of +1.7% reflects the variable expansion pattern. Current YoY growth of +2.5% is near this long-term average.
How is HOLX's revenue distributed by segment?
HOLX reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.